Real-time aggregation of research papers, AI models, datasets and regulatory updates.
Research Papers
370
From PubMed & arXiv
AI Models
33
Healthcare AI models
Regulatory Updates
15
FDA & compliance
Datasets
102
Medical datasets
Featured Content
RESEARCH HIGHLIGHT
BEGA-UNet: Boundary-Explicit Guided Attention U-Net with Multi-Scale Feature Aggregation for Colonoscopic Polyp Segmentation
Accurate polyp segmentation from colonoscopy images is critical for colorectal cancer prevention, yet the generalization of deep learning models under domain shift remains insufficiently explored. We propose Boundary-Explicit Guided Attention U-Net (BEGA-UNet), a boundary-aware segmentation architecture that introduces explicit edge modeling as a structural inductive bias to enhance both segmentation accuracy and cross-domain robustness. The framework integrates three components: an Edge-Guided Module (EGM) with learnable Sobel-initialized operators to capture boundary cues, a Dual-Path Attention (DPA) module that processes channel and spatial attention in parallel, and a Multi-Scale Feature Aggregation (MSFA) module to encode contextual information across multiple receptive fields. Evaluated on the combined Kvasir-SEG and CVC-ClinicDB benchmarks, BEGA-UNet achieves 88.53% Dice and 82.51% IoU, outperforming representative convolutional and transformer-based baselines. More importantly, cross-dataset evaluation demonstrates strong robustness under domain shift, with BEGA-UNet retaining 83.2% of its in-distribution performance--substantially higher than U-Net (64.5%), Attention U-Net (47.5%), and TransUNet (53.1%). In a zero-shot setting on an entirely unseen dataset, the model further maintains 72.6% performance retention. Comprehensive ablation studies indicate that explicit boundary modeling plays a central role in improving generalization, while multi-scale context aggregation further stabilizes performance across domains. Feature distribution analyses support this observation by showing that edge-oriented representations exhibit markedly reduced cross-domain variability compared to appearance-driven features. Overall, BEGA-UNet provides an effective and interpretable solution for robust polyp segmentation, demonstrating that explicit boundary modeling serves as a critical inductive bias for ensuring reliability under clinical domain shifts.
Largest MedGemma model optimized for medical text generation, clinical reasoning, and medical question answering. Trained on medical literature and clinical data.
Strong non-invasive tests (NITs) are needed to predict decompensation in patients with compensated advanced chronic liver disease (cACLD) and improve personalized patient care. We conducted a comprehensive review of the studies evaluating the effectiveness of NITs in predicting decompensation or liver-related death in patients with cACLD. A literature search was conducted in the PubMed database up to August 2025. Prospective or retrospective studies that included patients with cACLD and evaluated NITs for predicting decompensation or death or liver transplantation were included. Studies evaluating elastography and blood-based tests were analysed separately. The majority of studies assessed liver stiffness measurement (LSM), primarily using transient elastography (TE-LSM). There is a strong association between higher LSM values and an increased risk of decompensation, allowing classification of patients at low risk of decompensation from those with a higher risk. However, none of the studies reported data calibration, thereby limiting the ability to accurately predict the individual risk of decompensation. Higher FIB-4, ELF, and MELD values have been associated with an increased occurrence of decompensation. However, their performance was modest, with an area under the curve (AUC) below 0.75. Innovative approaches to improving the non-invasive prediction of decompensation may include levels of extracellular vesicles, genetic polymorphisms, or imaging-derived variables. Furthermore, since decompensation is the result of numerous interacting factors, artificial intelligence has the potential to improve the clinical relevance of predictive models by incorporating and processing a high-dimensional set of variables that reflect the underlying pathophysiological complexity.
Oligometastatic prostate cancer (oligoPCa) represents a clinical state of limited metastatic spread in which metastasis-directed therapy (MDT) may offer meaningful disease control either alone or with systemic therapy. As imaging, systemic therapy, and biologic characterization evolve, management strategies for both synchronous and metachronous presentations continue to undergo significant refinement.
Artificial intelligence (AI) is increasingly being explored as a tool to support more precise and dynamic management in the diagnosis and treatment of hematologic malignancies. Unlike previous reviews focused on single disease types or isolated technological pathways, this paper provides a comprehensive overview of AI’s current applications and latest advancements in diagnosis, classification, prognosis assessment, and treatment decision-making for leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. It encompasses key technical pathways, including morphology, imaging, flow cytometry, and multimodal data fusion, and further constructs an AI-driven dynamic diagnosis and treatment system along with its integrated deployment framework for electronic health records. This framework is intended to illustrate how multimodal data integration, dynamic risk assessment, and more coordinated longitudinal management could be supported within an integrated workflow. This integrated dynamic model provides a structured roadmap for intelligent, end-to-end management of hematologic malignancies and holds promise for advancing future intelligent clinical pathways. While AI demonstrates significant potential to enhance diagnostic consistency, optimize risk stratification, and enable personalized treatment, its development remains constrained by challenges such as data bottlenecks, insufficient cross-institutional model generalization, and ethical oversight. Future efforts should focus on advancing multicenter prospective validation, adhering to international standards like TRIPOD + AI, and refining data privacy, model interpretability, and ethical oversight systems. These advances may help support the future development of more personalized and dynamic patient management strategies within an evidence-based framework.
This article highlights some important nephrology studies published in 2025 that are relevant for many nonnephrologist physicians. Two studies examined aspects of acute kidney injury (AKI), including the use of sodium bicarbonate infusion to treat severe metabolic acidemia and the use of artificial intelligence models to predict AKI onset, severity, and complications. Three studies examined factors that may influence kidney function, including high-intensity long-term physical exercise, pregnancy, and the combined use of finerenone and empagliflozin. Three studies examined interventions to address common problems among patients receiving maintenance dialysis, including cognitive behavioral therapy for chronic pain, factor Xa inhibitors for atrial fibrillation, and fish oil for cardiovascular events.
AI-based image analysis is increasingly applied in pathology. Excluding fungal elements in PAS-stained skin sections is labor-intensive and well suited for AI assistance. While fungal detection in nails has been studied, skin-biopsy applications and real-world benefit remain limited. This study aimed to develop an AI algorithm for fungal detection in skin histology, create intuitive visualization software, and assess its diagnostic utility for pathologists.
One of the most common consequences in individuals with diabetes is the diabetic foot, which can cause foot ulcers and even lead to limb amputation. Since an increase of the temperature in the plantar region is directly correlated with an increased risk of ulceration, infrared thermography (IRT) has been used in multiple studies as an automatic tool for detecting problems in diabetic foot. Artificial intelligence-based computer-aided diagnosis systems are being more frequently used to improve decision-making and minimize errors. These technologies are designed to increase examination accuracy, consistency in image interpretation, prognosis evaluation support, and examination accuracy. They also have the ability to offer insightful information and help medical professionals to manage diabetic foot issues successfully.
To systematically evaluate the contribution of clinical heterogeneity to chronic kidney disease (CKD) progression in gout patients using data-driven phenotyping, and to assess whether incorporating genetic risk improves prediction of renal outcomes.
Artificial intelligence research in orthopedics has grown rapidly, yet a substantial gap remains between technical development and clinical translation. This narrative review summarizes current applications of artificial intelligence in orthopedic practice and highlights barriers to implementation.